These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2151791)

  • 1. The behaviour of suppressor-inducer T cells following treatment for Graves' disease.
    Wilson R; Pearson C; McKillop JH; Burnett AK; Thomson JA
    Autoimmunity; 1990; 6(1-2):93-7. PubMed ID: 2151791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.
    Charreire J; Karsenty G; Bouchard P; Schaison G
    Clin Exp Immunol; 1984 Sep; 57(3):633-8. PubMed ID: 6147216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
    Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R
    Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease.
    Ishikawa N; Eguchi K; Otsubo T; Ueki Y; Fukuda T; Tezuka H; Matsunaga M; Kawabe Y; Shimomura C; Izumi M
    J Clin Endocrinol Metab; 1987 Jul; 65(1):17-23. PubMed ID: 2953751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.
    Tötterman TH; Karlsson FA; Bengtsson M; Mendel-Hartvig I
    N Engl J Med; 1987 Jan; 316(1):15-22. PubMed ID: 2946953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of B-cell, T-helper-cell, and T-suppressor-cell function in patients with Graves' disease before and after treatment with anti-thyroid drugs.
    Jones BM; Teng CS; Yeung RT
    Clin Immunol Immunopathol; 1982 Nov; 25(2):232-42. PubMed ID: 6219845
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
    Karlsson FA; Tötterman TH
    Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered balance of immunoregulatory T lymphocyte subsets in autoimmune thyroid diseases.
    Misaki T; Konishi J; Iida Y; Endo K; Torizuka K
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):200-4. PubMed ID: 6229968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated T cells in Graves' disease before treatment.
    Kennedy R; Di Mario U; Pozzilli P; Guy K; Leonardi M; Sensi M; Andreani D
    Clin Exp Immunol; 1985 Feb; 59(2):377-82. PubMed ID: 3156702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anomalies of cellular immunity in Graves' disease treated by synthetic antithyroid drugs: effects on prognosis].
    Allannic H; Genetet N; Edan G; Merdrignac G; Simon M; Genetet B
    Pathol Biol (Paris); 1987 Dec; 35(10):1333-8. PubMed ID: 2449649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole.
    Ludgate ME; McGregor AM; Weetman AP; Ratanachaiyavong S; Lazarus JH; Hall R; Middleton GW
    Br Med J (Clin Res Ed); 1984 Feb; 288(6416):526-30. PubMed ID: 6421364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathyroidal accumulation of T cell phenotypes in autoimmune thyroid disease.
    Martin A; Goldsmith NK; Friedman EW; Schwartz AE; Davies TF; Roman SH
    Autoimmunity; 1990; 6(4):269-81. PubMed ID: 1716476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of peripheral T lymphocyte subpopulations in Graves' disease.
    Okabe N; Inoue K; Mori R
    J Clin Lab Immunol; 1983 Feb; 10(2):91-5. PubMed ID: 6221106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunction of suppressor T cells in thyroid glands from patients with Graves' disease.
    Ueki Y; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Shimomura C; Matsunaga M; Tezuka H; Ishikawa N; Ito K
    J Clin Endocrinol Metab; 1987 Nov; 65(5):922-8. PubMed ID: 2959679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of plasmapheresis and drug immunosuppression on T-cell subsets as defined by monoclonal antibodies.
    Kiprov DD; Dau PC; Morand P
    J Clin Apher; 1983; 1(2):57-63. PubMed ID: 6152658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-lymphocyte activation in adult-onset idiopathic hypoparathyroidism.
    Wortsman J; McConnachie P; Baker JR; Mallette LE
    Am J Med; 1992 Apr; 92(4):352-6. PubMed ID: 1348395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating activated T cell subsets in autoimmune thyroid diseases: differences between untreated and treated patients.
    Ohashi H; Okugawa T; Itoh M
    Acta Endocrinol (Copenh); 1991 Nov; 125(5):502-9. PubMed ID: 1684685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of low doses of prednisolone on the traffic of T helper-inducer cells in rheumatoid arthritis.
    Verbruggen G; Veys EM; Hermanns P; Delanghe J; Vansteenkiste M
    Clin Rheumatol; 1982 Sep; 1(3):199-207. PubMed ID: 6236014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of immunoglobulin synthesis in cultures of peripheral T and B lymphocytes: reduced T-suppressor cell activity in Graves' disease.
    Pacini F; DeGroot LJ
    Clin Endocrinol (Oxf); 1983 Mar; 18(3):219-32. PubMed ID: 6222851
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased suppressor T-lymphocytes in autoimmune thyroid diseases detected by monoclonal antibodies.
    Sridama V; Pacini F; DeGroot LJ
    J Clin Endocrinol Metab; 1982 Feb; 54(2):316-9. PubMed ID: 6459338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.